










|

Senior Scientist, Neuroscience, Ottawa Hospital Research Institute
Associate Director, Ottawa Hospital Research Institute
Professor, Department of Medicine, Division of Neurology, Department of Molecular and Cellular Medicine, University of Ottawa
Research Interests
Synaptic transmission, neurotransmitters, neuropeptides
Neural control of neuroendocrine and autonomic function
Major research activities
Dr. Renaud is interested in the neurophysiology and pharmacology of synaptic transmission in the mammalian central nervous system with a particular interest in defining the cellular and molecular neuronal mechanisms operative in hypothalamic, brainstem and spinal cord circuits that subserve neuroendocrine and autonomic functions. The approach is multidisciplinary, applied to both in vivo and in vitro preparations, and uses extra- and intracellular electrophysiology, patch clamp techniques, chemospecific lesions, anterograde and retrograde tracers, immunocytochemistry, early gene (c-Fos) expression, in-situ hybridization, electron microscopy and radioimmunoassay.
Earlier electrophysiological studies revealed that the excitability of magnocellular neurosecretory neurons in the hypothalamic supraoptic and paraventricular nuclei governs hormone (vasopressin and oxytocin) release from their posterior pituitary axon terminals. CNS control of posterior pituitary hormone secretion requires characterization of the factors that control the excitability of magnocellular neurosecretory neurons. In-vivo this research is focused on defining CNS circuitry that conveys information to these cells from osmoreceptors, baroreceptors, volume receptors, and circumventricular organs. In-vitro slice, explant, and dissociated cell preparations together with intracellular and patch clamp techniques are used to define intrinsic membrane properties and ligand-gated conductances that are unique to the magnocellular neurons, and to cells located along the lamina terminalis whose axons synapse directly with magnocellular neurons. This knowledge will contribute to understanding how the brain senses and adjusts for moment to moment alterations in hydromineral balance and cardiovascular functions. (Funded by The Canadian Institutes of Health Research (CIHR)).
The hypothalamus is a major contributor to central regulation of autonomic functions, and specific populations of medial hypothalamic neurons project their axons directly to brainstem and spinal autonomic centres. Participating in these descending pathways are vasopressin and oxytocin-immunoreactive parvocellular neurons in the paraventricular nucleus, whose axons target spinal preganglionic neurons located in the intermediolateral cell column. Using patch clamp and double-label techniques, Dr Renaud's lab is investigating signalling mechanisms in spinal preganglionic neurons from descending and local pathways, their neuropharmacology and signalling at G-protein-coupled vasopressin and oxytocin receptors. (Funded by The Canadian Institutes of Health Research (CIHR)).
Mammals are known to demonstrate diurnal rhythms in various neuroendocrine and cardiovascular functions, rhythms that may contribute to the time of occurrence of cerebral and/or myocardial ischemic events. Central control of neuroendocrine and autonomic functions reside with at least three different populations of "output" neurons located in the hypothalamic paraventricular nucleus, whereas the central source of the diurnal rhythmicity is believed to reside within neurons in the adjacent suprachiasmatic nucleus, a circadian pacemaker in mammalian brain. On the hypothesis that suprachiasmatic nucleus neurons transfer their rhythmicity synaptically to different populations of paraventricular nucleus output cells, Dr Renaud has initiated another series of collaborative investigations intended to characterize the synaptic connectivity and neurotransmitters involved in suprachiasmatic nucleus inputs to paraventricular nucleus neurons. A variety of techniques serve to differentiate paraventricular nucleus neurons according to their axon targets: to the median eminence, to regulate anterior pituitary function; the posterior pituitary, to regulate plasma vasopressin and oxytocin levels; to brainstem and spinal cord autonomic centres, to control cardiovascular and adrenomedullary function. (Funded by the Heart and Stroke Foundation).
Major Awards/Affiliations
Affiliations
1999-present University of Ottawa, Director, Research, Department of Medicine
2001 - present Associate Director, Ottawa Hospital Research Institute
Awards & Honours
2005 Distinguished Scientist Award, Canadian Society of Clinical Investigation
2005 Biomedical Science Ambassador Award, FCIHR; Partners in Research
2005 University of Ottawa Alumni, Faculty of Medicine, University of Ottawa
2003 Award of Excellence, University of Ottawa, Faculty of Medicine
2002 Career Achievement Award, Ottawa Life Sciences Council
2001 David Grimes Career Achievement Award, Ottawa Hospital Foundation
2000 Fellow, Royal Society of Canada
1998 Sarrazin Lecturer, Canadian Physiological Society
Most Recent Publications (provided by The Ottawa Hospital Library Database)
Hermes ML;Kolaj M;Doroshenko P;Coderre E;Renaud LP;, (2009 Sep), Effects of VPAC2 receptor activation on membrane excitability and GABAergic transmission in subparaventricular zone neurons targeted by suprachiasmatic nucleus, J Neurophysiol, Vol.102, Issue 3, 1834-1842 -> view abstract
Zhang L;Renaud LP;Kolaj M;, (2009 Jun), Properties of a T-type Ca2+channel-activated slow afterhyperpolarization in thalamic paraventricular nucleus and other thalamic midline neurons, J Neurophysiol, Vol.101, Issue 6, 2741-2750 -> view abstract
Doroshenko P;Renaud LP;, (2009 Feb 18), Acid-sensitive TASK-like K(+) conductances contribute to resting membrane potential and to orexin-induced membrane depolarization in rat thalamic paraventricular nucleus neurons, Neuroscience, Vol.158, Issue 4, 1560-1570 -> view abstract
Kolaj M;Coderre E;Renaud LP;, (2008 Sep 9), Orexin peptides enhance median preoptic nucleus neuronal excitability via postsynaptic membrane depolarization and enhancement of glutamatergic afferents, Neuroscience, Vol.155, Issue 4, 1212-1220 -> view abstract
Oz M;Yang KH;Shippenberg TS;Renaud LP;O'Donovan MJ;, (2007 Sep), Cholecystokinin B-type receptors mediate a G-protein-dependent depolarizing action of sulphated cholecystokinin ocatapeptide (CCK-8s) on rodent neonatal spinal ventral horn neurons, J Neurophysiol , Vol.98, Issue 3, 1108-1114 -> view abstract
Kolaj M;Renaud LP;, (2007 May), Presynaptic alpha-adrenoceptors in median preoptic nucleus modulate inhibitory neurotransmission from subfornical organ and organum vasculosum lamina terminalis2, American Journal of Physiology - Regulatory Integrative & Comparative Physiology, Vol.292, Issue 5, R1907
Kolaj M;Doroshenko P;Yan C;Coderre E;Renaud LP;, (2007 Jul 29), Orexin-induced modulation of state-dependent intrinsic properties in thalamic paraventricular nucleus neurons attenuates action potential patterning and frequency1, Neuroscience, Vol.147, Issue 4, 1066-1075
van den Top M;Lyons DJ;Lee K;Coderre E;Renaud LP;Spanswick D;, (2007 Feb 9), Pharmacological and molecular characterization of ATP-sensitive K(+) conductances in CART and NPY/AgRP expressing neurons of the hypothalamic arcuate nucleus, Neuroscience, Vol.144, Issue 3, 815-824 -> view abstract
Zhang L;Kolaj M;Renaud LP;, (2006 Sep 15), Suprachiasmatic nucleus communicates with anterior thalamic paraventricular nucleus neurons via rapid glutamatergic and gabaergic neurotransmission: state-dependent response patterns observed in vitro4, Neuroscience, Vol.141, Issue 4, 2059-2066
Richter TA;Kolaj M;Renaud LP;, (2006 Sep), Heterogeneity in low voltage-activated Ca2+ channel-evoked Ca2+ responses within neurons of the thalamic paraventricular nucleus3, European Journal of Neuroscience, Vol.24, Issue 5, 1316-1324
| |